Annual SG&A
$18.13 M
+$889.00 K+5.16%
30 April 2024
Summary:
Champions Oncology annual selling, general & administrative expenses is currently $18.13 million, with the most recent change of +$889.00 thousand (+5.16%) on 30 April 2024. During the last 3 years, it has risen by +$6.10 million (+50.69%). CSBR annual SG&A is now at all-time high.CSBR Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$4.21 M
-$332.00 K-7.32%
31 July 2024
Summary:
Champions Oncology quarterly selling, general & administrative expenses is currently $4.21 million, with the most recent change of -$332.00 thousand (-7.32%) on 31 July 2024. Over the past year, it has dropped by -$189.00 thousand (-4.30%). CSBR quarterly SG&A is now -9.28% below its all-time high of $4.64 million, reached on 31 July 2023.CSBR Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$334.31 M
-$3.40 M-1.03%
31 July 2024
Summary:
Champions Oncology TTM selling, general & administrative expenses is currently -$334.31 million, with the most recent change of -$3.40 million (-1.03%) on 31 July 2024. Over the past year, it has dropped by -$352.27 million (-1961.83%). CSBR TTM SG&A is now -6586.22% below its all-time high of $18.19 million, reached on 31 January 2024.CSBR TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSBR Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.2% | -4.3% | -1961.8% |
| 3 y3 years | +50.7% | +16.4% | -2493.2% |
| 5 y5 years | +134.4% | +99.2% | -3901.2% |
CSBR Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +50.7% | -9.3% | +16.4% | -16.0% | at low |
| 5 y | 5 years | at high | +134.4% | -9.3% | +99.2% | -17.9% | at low |
| alltime | all time | at high | >+9999.0% | -9.3% | +4747.5% | -6586.2% | at low |
Champions Oncology Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | $4.21 M(-7.3%) | $17.70 M(-2.4%) |
| Apr 2024 | $18.13 M(+5.2%) | $4.54 M(-0.5%) | $18.13 M(-0.3%) |
| Jan 2024 | - | $4.56 M(+3.8%) | $18.19 M(+1.3%) |
| Oct 2023 | - | $4.39 M(-5.2%) | $17.96 M(+0.9%) |
| July 2023 | - | $4.64 M(+0.9%) | $17.79 M(+3.2%) |
| Apr 2023 | $17.24 M(+11.3%) | $4.59 M(+6.1%) | $17.24 M(+1.3%) |
| Jan 2023 | - | $4.33 M(+2.4%) | $17.02 M(+3.4%) |
| Oct 2022 | - | $4.23 M(+3.3%) | $16.47 M(+3.9%) |
| July 2022 | - | $4.09 M(-6.5%) | $15.86 M(+2.3%) |
| Apr 2022 | $15.50 M(+28.8%) | $4.38 M(+15.9%) | $15.49 M(+7.5%) |
| Jan 2022 | - | $3.78 M(+4.5%) | $14.42 M(+3.2%) |
| Oct 2021 | - | $3.62 M(-3.0%) | $13.97 M(+6.1%) |
| July 2021 | - | $3.73 M(+13.0%) | $13.17 M(+9.5%) |
| Apr 2021 | $12.03 M(+10.8%) | $3.30 M(-0.9%) | $12.03 M(-2.3%) |
| Jan 2021 | - | $3.33 M(+18.2%) | $12.32 M(+3.9%) |
| Oct 2020 | - | $2.82 M(+8.7%) | $11.85 M(+6.3%) |
| July 2020 | - | $2.59 M(-27.7%) | $11.15 M(+2.7%) |
| Apr 2020 | $10.86 M(+40.4%) | $3.58 M(+25.1%) | $10.85 M(+13.6%) |
| Jan 2020 | - | $2.86 M(+35.6%) | $9.56 M(+8.7%) |
| Oct 2019 | - | $2.11 M(-8.0%) | $8.79 M(+4.0%) |
| July 2019 | - | $2.30 M(+0.5%) | $8.46 M(+9.3%) |
| Apr 2019 | $7.73 M(+16.5%) | $2.29 M(+8.7%) | $7.73 M(+9.5%) |
| Jan 2019 | - | $2.10 M(+18.5%) | $7.06 M(+7.1%) |
| Oct 2018 | - | $1.77 M(+12.8%) | $6.59 M(+4.3%) |
| July 2018 | - | $1.57 M(-2.4%) | $6.32 M(-4.8%) |
| Apr 2018 | $6.64 M(-19.2%) | $1.61 M(-1.2%) | $6.64 M(-11.3%) |
| Jan 2018 | - | $1.63 M(+8.4%) | $7.49 M(+0.9%) |
| Oct 2017 | - | $1.50 M(-20.5%) | $7.42 M(-3.1%) |
| July 2017 | - | $1.89 M(-23.2%) | $7.66 M(-6.9%) |
| Apr 2017 | $8.22 M(-4.6%) | $2.46 M(+57.6%) | $8.22 M(+7.8%) |
| Jan 2017 | - | $1.56 M(-10.2%) | $7.63 M(-3.3%) |
| Oct 2016 | - | $1.74 M(-29.3%) | $7.89 M(-9.2%) |
| July 2016 | - | $2.46 M(+31.6%) | $8.68 M(+1.3%) |
| Apr 2016 | $8.62 M(-10.4%) | $1.87 M(+2.6%) | $8.57 M(-5.2%) |
| Jan 2016 | - | $1.82 M(-28.2%) | $9.04 M(-3.8%) |
| Oct 2015 | - | $2.53 M(+8.0%) | $9.40 M(-0.5%) |
| July 2015 | - | $2.35 M(+0.3%) | $9.45 M(-1.6%) |
| Apr 2015 | $9.62 M(+3.7%) | $2.34 M(+7.3%) | $9.60 M(-3.1%) |
| Jan 2015 | - | $2.18 M(-15.5%) | $9.90 M(-7.1%) |
| Oct 2014 | - | $2.58 M(+3.4%) | $10.66 M(+6.0%) |
| July 2014 | - | $2.50 M(-5.7%) | $10.06 M(+8.4%) |
| Apr 2014 | $9.28 M(+27.2%) | $2.65 M(-10.0%) | $9.28 M(+10.5%) |
| Jan 2014 | - | $2.94 M(+48.8%) | $8.40 M(+15.7%) |
| Oct 2013 | - | $1.98 M(+15.4%) | $7.26 M(+1.3%) |
| July 2013 | - | $1.71 M(-2.9%) | $7.16 M(-1.8%) |
| Apr 2013 | $7.30 M(-12.9%) | $1.76 M(-2.1%) | $7.30 M(-4.0%) |
| Jan 2013 | - | $1.80 M(-4.1%) | $7.60 M(-1.4%) |
| Oct 2012 | - | $1.88 M(+1.8%) | $7.71 M(-3.0%) |
| July 2012 | - | $1.85 M(-10.9%) | $7.95 M(-6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2012 | $8.38 M(+47.1%) | $2.07 M(+8.5%) | $8.51 M(-6.8%) |
| Jan 2012 | - | $1.91 M(-9.9%) | $9.13 M(+1.9%) |
| Oct 2011 | - | $2.12 M(-11.8%) | $8.96 M(+18.6%) |
| July 2011 | - | $2.40 M(-10.6%) | $7.56 M(+28.3%) |
| Apr 2011 | $5.70 M(+73.4%) | $2.69 M(+54.3%) | $5.89 M(+40.6%) |
| Jan 2011 | - | $1.74 M(+143.6%) | $4.19 M(+37.8%) |
| Oct 2010 | - | $716.00 K(-3.0%) | $3.04 M(-5.4%) |
| July 2010 | - | $738.00 K(-25.5%) | $3.22 M(-2.1%) |
| Apr 2010 | $3.28 M(+54.4%) | $991.00 K(+66.3%) | $3.28 M(+0.8%) |
| Jan 2010 | - | $596.00 K(-33.1%) | $3.26 M(+4.3%) |
| Oct 2009 | - | $891.00 K(+10.5%) | $3.12 M(+17.6%) |
| July 2009 | - | $806.00 K(-16.4%) | $2.66 M(+21.6%) |
| Apr 2009 | $2.13 M(+85.0%) | $964.00 K(+108.2%) | $2.18 M(+32.1%) |
| Jan 2009 | - | $463.00 K(+9.5%) | $1.65 M(+9.5%) |
| Oct 2008 | - | $422.90 K(+26.6%) | $1.51 M(+25.2%) |
| July 2008 | - | $334.00 K(-22.9%) | $1.21 M(+7.8%) |
| Apr 2008 | $1.15 M(+576.1%) | $433.00 K(+35.3%) | $1.12 M(+43.1%) |
| Jan 2008 | - | $320.00 K(+168.2%) | $782.10 K(+56.6%) |
| Oct 2007 | - | $119.30 K(-51.7%) | $499.30 K(+24.9%) |
| July 2007 | - | $246.80 K(+157.1%) | $399.60 K(+134.9%) |
| Apr 2007 | $170.10 K(+18.0%) | $96.00 K(+158.1%) | $170.10 K(+138.2%) |
| Jan 2007 | - | $37.20 K(+89.8%) | $71.40 K(-25.4%) |
| Oct 2006 | - | $19.60 K(+13.3%) | $95.70 K(-20.2%) |
| July 2006 | - | $17.30 K(-740.7%) | $119.90 K(-30.5%) |
| Apr 2006 | $144.10 K(+36.6%) | -$2700.00(-104.4%) | $172.60 K(+103.5%) |
| Jan 2006 | - | $61.50 K(+40.4%) | $84.80 K(0.0%) |
| Oct 2005 | - | $43.80 K(-37.4%) | $84.80 K(-27.3%) |
| July 2005 | - | $70.00 K(-177.3%) | $116.60 K(+10.6%) |
| Apr 2005 | $105.50 K(-92.8%) | -$90.50 K(-247.2%) | $105.40 K(-78.0%) |
| Jan 2005 | - | $61.50 K(-18.7%) | $479.10 K(-37.8%) |
| Oct 2004 | - | $75.60 K(+28.6%) | $769.70 K(-27.0%) |
| July 2004 | - | $58.80 K(-79.2%) | $1.05 M(-25.1%) |
| Apr 2004 | $1.46 M(-9.1%) | $283.20 K(-19.6%) | $1.41 M(-7.9%) |
| Jan 2004 | - | $352.10 K(-2.4%) | $1.53 M(-1.1%) |
| Oct 2003 | - | $360.60 K(-12.4%) | $1.55 M(-1.9%) |
| July 2003 | - | $411.80 K(+1.9%) | $1.57 M(-1.7%) |
| Apr 2003 | $1.60 M(+0.1%) | $404.10 K(+9.5%) | $1.60 M(-0.7%) |
| Jan 2003 | - | $369.00 K(-5.4%) | $1.61 M(-2.3%) |
| Oct 2002 | - | $389.90 K(-11.2%) | $1.65 M(+1.0%) |
| July 2002 | - | $439.00 K(+5.8%) | $1.64 M(+2.2%) |
| Apr 2002 | $1.60 M(-5.2%) | $415.10 K(+1.8%) | $1.60 M(+13.4%) |
| Jan 2002 | - | $407.60 K(+9.0%) | $1.41 M(-11.7%) |
| Oct 2001 | - | $373.90 K(-7.3%) | $1.60 M(-5.6%) |
| July 2001 | - | $403.40 K(+78.5%) | $1.69 M(+0.2%) |
| Apr 2001 | $1.69 M(+423.3%) | $226.00 K(-62.0%) | $1.69 M(+6.5%) |
| Jan 2001 | - | $594.00 K(+27.0%) | $1.58 M(+45.3%) |
| Oct 2000 | - | $467.90 K(+17.1%) | $1.09 M(+75.2%) |
| July 2000 | - | $399.70 K(+226.3%) | $622.20 K(+179.6%) |
| Apr 2000 | $322.50 K | $122.50 K(+22.5%) | $222.50 K(+122.5%) |
| Jan 2000 | - | $100.00 K | $100.00 K |
FAQ
- What is Champions Oncology annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Champions Oncology?
- What is Champions Oncology annual SG&A year-on-year change?
- What is Champions Oncology quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Champions Oncology?
- What is Champions Oncology quarterly SG&A year-on-year change?
- What is Champions Oncology TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Champions Oncology?
- What is Champions Oncology TTM SG&A year-on-year change?
What is Champions Oncology annual selling, general & administrative expenses?
The current annual SG&A of CSBR is $18.13 M
What is the all time high annual SG&A for Champions Oncology?
Champions Oncology all-time high annual selling, general & administrative expenses is $18.13 M
What is Champions Oncology annual SG&A year-on-year change?
Over the past year, CSBR annual selling, general & administrative expenses has changed by +$889.00 K (+5.16%)
What is Champions Oncology quarterly selling, general & administrative expenses?
The current quarterly SG&A of CSBR is $4.21 M
What is the all time high quarterly SG&A for Champions Oncology?
Champions Oncology all-time high quarterly selling, general & administrative expenses is $4.64 M
What is Champions Oncology quarterly SG&A year-on-year change?
Over the past year, CSBR quarterly selling, general & administrative expenses has changed by -$189.00 K (-4.30%)
What is Champions Oncology TTM selling, general & administrative expenses?
The current TTM SG&A of CSBR is -$334.31 M
What is the all time high TTM SG&A for Champions Oncology?
Champions Oncology all-time high TTM selling, general & administrative expenses is $18.19 M
What is Champions Oncology TTM SG&A year-on-year change?
Over the past year, CSBR TTM selling, general & administrative expenses has changed by -$352.27 M (-1961.83%)